1Bandera E,Botterri M,Minelli C. Cerebral blood flow threshold of ischemic punumbra and infarct core in acute ischemic stroke:a systematic review[J].Stroke,2006,(05):1334-1339.
2Grotta JC,Welch KM,Fagan SC. Clinical deterioration following improvement in the NINDS rt-PA stroke trial[J].Stroke,2001,(03):661-668.
3Ribo M,Molina C,Montaner J. Acute hyperglycemia state is associated with lower rtPA-induced recanalization rates in stroke patients[J].Stroke,2005,(08):1705-1709.
4Bruno A,Levine SR,Frankel MR. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial[J].Neurology,2002,(05):669-674.
5Saposnik G,Di Legge S,Webster F. Predictors of major neurologic improvement after thrombolysis in acute stroke[J].Neurology,2005,(08):1169-1174.
6Wahlgren N,Ahmed N,Eriksson N. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials:Safe Implementation of Thrombolysis in Stroke-Monitoring Study(SITS-MOST)[J].Stroke,2008,(12):3316-3322.doi:10.1161/STROKEAHA.107.510768.
8Amold M,Schroth G,Nedeltchev K. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion[J].Stroke,2002,(07):1828-1833.
9Yoneda Y,Yamamoto S,Hara Y. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit[J].Clinical Neurology and Neurosurgery,2007,(07):567-570.doi:10.1016/j.clineuro.2007.05.002.
10Liao JK,Shin WS,Lee WY. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase[J].J Bioil Chem,1995,(01):319-324.
二级参考文献20
1Kaste M.Thrombolysis.What more does it take[J]? Stroke,2005,36:200-202.
2Arora S,Broderick JP,Frankel M,et al.Acute stroke care in the US:results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry[J].Stroke,2005,36:1232-1240.
3Calfornia Acute Stroke Pilot Registry (CASPR) Investigations.Prioritizing interventions to improve rates of thrombolysis for ischemic stroke[J].Neurology,2005,64:654-659.
4Cocho D,Belvis R,Marti-Fabregas J,et al.Reasons for exclusion from thrombolytic therapy following acute ischemic stroke[J].Neurology,2005,64:719-720.
5Katzan IL,Hammer MD,Hixon ED,et al.Utilization of intravenous tissue plasminogen activator for acute ischemic stroke[J].Arch Neurol,2004,61:346-350.
6Graham GD.Tissue plasminogen activator for acute ischemic stroke in clinical practice:a meta-analysis of safety data[J].Ann Neurol,2002,52(suppl 1):524.
7Ergin A,Ergin N.Is thrombolytic therapy associated with increased mortality? Meta-analysis of randomized controlled trials[J].Arch Neurol,2005,62:362-366.
8Hill MD,Buchan AM.Thrombolysis for acute ischemic stroke:results of the Canadian Alteplase for Stroke Effectiveness Study[J].CMAJ,2005,172:1307-1312.
9The IMS Study Investigators.Combined intravenous and intra-arterial recanalization for acute ischemic stroke:The Interventional Management of Stroke Study[J].Stroke,2004,35:904-911.
10Flaherty ML,Woo D,Kissela B,et al.Combined IV and intra-arterial thrombolysis for acute ischemic stroke[J].Neurology,2005,64:386-388.
7GROTTA J C, WELCH K M, FAGAN S C, et al. Clinical deterioration following improvement in the NINDS rt-PA stroke trial[ J]. Stroke,2001,32(3 ) :661-668.
8Spinella PC,Holcomb JB. Resuscitation and transfusion principles for traumatic hemorrhagic shock [J]. Blood Rev,2009,23(6) :231-240.
9Sorensen B, Ingerslev J. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemo- static response using thrombelastography [J]. Haemophilia, 2005,11 (Suppll) : 1-6.
10The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen ac- tivator for acute ischemic stroke [J]. N Engl J Med, 1995, 333(24):1581-1587.
